Managing Agitated Delirium in Palliative Care

This chapter explores a study assessing the effectiveness of various medications, including lorazepam and haloperidol, in treating agitated delirium in end-of-life patients. It emphasizes the importance of personalized care approaches and the emotional burden on patients and caregivers, alongside the need for further research that includes a wider patient demographic. Key metrics for evaluating treatment efficacy and the role of caregivers in understanding patient experiences are also highlighted.